NRIP1 and adenocarcinoma: As shown in Figure 5, the comparison of the patients simultaneously expressing PRA and RIP140 (n = 8) to all other patients (n = 39) within the adenocarcinoma group (n = 47) showed a highly significant trend (p < 0.001).